The government's decision to introduce the long-discussed hepatitis C antibody testing to the national screening program is expected to have a positive impact on its treatment market.

According to industry sources, the decision is encouraging as it enables the first step of identifying hepatitis C patients. However, how to link diagnosis and treatment will be a challenge in the future, as the treatment rate has been dropping despite patient identification.

Recently, the Ministry of Health and Welfare held the 2nd National Health Screening Committee Meeting in 2024 and confirmed the introduction of new hepatitis C testing and the expansion of osteoporosis screening subjects in Ko